Phase 1 Haemophilia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are male
- People who are between 18 and 64 years old (inclusive) at the time of signing the consent form
- People who weigh 45 kilograms or more
- People who have been diagnosed with congenital haemophilia A (meaning they were born with it) with a factor VIII activity level of 15% or lower, with or without inhibitors (antibodies that block factor VIII treatment), based on their medical records
Who may not be able to join:
- People who are currently using or have recently used any preventative (prophylactic) treatment for haemophilia A within a specific timeframe based on how long that medication stays in the body
- People whose body mass index (a measure of body weight relative to height) is 30 or higher
- People who have a higher-than-normal risk of blood clots — for example, if they or a close blood relative have had an unexplained deep vein thrombosis (a blood clot in a deep vein)
- People who have any signs or a confirmed diagnosis of a disease involving blood clots in the veins or arteries
- People who have any known blood clotting disorder other than haemophilia A
- People who are currently receiving or planning to start immune tolerance induction therapy (a treatment designed to reduce the body's resistance to factor VIII)
- People who have significant digestive system conditions that may affect how the body absorbs medications or nutrients, as determined by the trial investigator
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Transparency (dept. 2834), Novo Nordisk A/S
Phone: (+1) 866-867-7178
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of treatment emergent adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.